Anchen Laboratories, Inc. - Anchen's Branded Product Division

 

The early success of Anchen's high-value niche generic program solidified the company's financial framework and set in motion innovation towards a larger corporate vision with the launch of an NDA division-Anchen Laboratories, Inc.

 

Anchen Labs is on a path to build a highly-valued and self-sustaining portfolio of new pharmaceutical products for branded commercialization in the United States and the rest of the world. Anchen Labs targets potential new drug candidates that will fill unmet medical needs, and seeks to leverage the company's existing research, drug delivery and clinical development capabilities.

 

Anchen Labs' strategy for success is to align all key aspects of drug development and commercialization from the beginning to ensure maximum return on investment and more efficient and relevant allocation of resources over the long term. Such an approach will provide Anchen with the insights necessary to focus investments on business opportunities most likely to show not only a clear benefit for patients but also profitable returns, both of which are necessary for a successful NDA program.